Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages

FEMS Immunology and Medical Microbiology

Volumn 47, Issue 3, 2006, Pages 369-379

  Sabet, Mojgan ^a   Cottam, Howard B ^b   Guiney, Donald G ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Anthrax; Cytokines; Cytotoxicity; Macrophages; TLR7 9 ligands

Indexed keywords

2 [4 AMINO 2 (ETHOXYMETHYL) 1H IMIDAZO[4,5 C]QUINOLIN 1 YL]ETHANOL; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; ISS 1018; IT 37; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID; QUINOLINE DERIVATIVE; RESIQUIMOD; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPORE GERMINATION;

AMINOQUINOLINES; ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; IMIDAZOLES; LIGANDS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED A; SPORES, BACTERIAL; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 33745857009     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00096.x     Document Type: Article

References (51)

1. Abramova FA, Grinberg LM, Yampolskaya OV & Walker DH (1993) Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA 90: 2291-2294.
2. Akira S (2003a) Mammalian Toll-like receptors. Curr Opin Immunol 15: 5-11.
3. Akira S (2003b) Toll-like receptor signaling. J Biol Chem 278: 38105-38108.
4. Cho JY, Miller M, Baek KJ, Castaneda D, Nayar J, Roman M, Raz E & Broide DH (2001) Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J Allergy Clin Immunol 108: 697-702.
5. Colino J & Snapper CM (2003) Opposing signals from pathogen-associated molecular patterns and IL-10 are critical for optimal dendritic cell induction of in vivo humoral immunity to Streptococcus pneumoniae. J Immunol 171: 3508-3519.
6. Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM & Standiford TJ (2004) CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J Immunol 173: 5148-5155.
7. Erwin JL, DaSilva LM, Bavari S, Little SF, Friedlander AM & Chanh TC (2001) Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun 69: 1175-1177.
8. Gangloff SC & Guenounou M (2004) Toll-like receptors and immune response in allergic disease. Clin Rev Allergy Immunol 26: 115-125.
9. Gleiser CA (1967) Pathology of anthrax infection in animal hosts. Fed Proc 26: 1518-1521.
10. Gold JA, Hoshino Y, Hoshino S, Jones MB, Nolan A & Weiden MD (2004) Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect Immun 72: 1291-1297.
11. Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X, Tomai MA, Alkan SS & Vasilakos JP (2005) Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 174: 1259-1268.
12. Guidi-Rontani C, Weber-Levy M, Labruyere E & Mock M (1999) Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 31: 9-17.
13. Guidi-Rontani C, Levy M, Ohayon H & Mock M (2001) Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol 42: 931-938.
14. Hanna PC, Acosta D & Collier RJ (1993) On the role of macrophages in anthrax. Proc Natl Acad Sci USA 90: 10198-10201.
15. Hanna PC, Kruskal BA, Ezekowitz RA, Bloom BR & Collier RJ (1994) Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med 1: 7-18.
16. Hayashi T, Rao SP, Takabayashi K, van Uden JH, Kornbluth RS, Baird SM, Taylor MW, Carson DA, Catanzaro A & Raz E (2001) Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infect Immun 69: 6156-6164.
17. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ, Eckmann L, Guiney DJ & Karin M (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345.
18. Ireland JA & Hanna PC (2002) Macrophage-enhanced germination of Bacillus anthracis endospores requires gerS. Infect Immun 70: 5870-5872.
19. Jernigan JA, Stephens DS, Ashford DA, et al. (2001) Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7: 933-944.
20. Jernigan DB, Raghunathan PL, Bell BP, et al. (2002) Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 8: 1019-1028.
21. Kalamas AG (2004) Anthrax. Anesthesiol Clin North America 22: 533-540, vii.
22. Kenney RT, Yu J, Guebre-Xabier M, Frech SA, Lambert A, Heller BA, Ellingsworth LR, Eyles JE, Williamson ED & Glenn GM (2004) Induction of protective immunity against lethal anthrax challenge with a patch. J Infect Dis 190: 774-782.
23. Kirby JE (2004) Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun 72: 430-439.
24. Krieg AM, Love-Homan L, Yi AK & Harty JT (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 161: 2428-2434.
25. Lee J, Chuang TH, Redecke V, She L, Pitha PM, Carson DA, Raz E & Cottam HB (2003) Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 100: 6646-6651.
26. Miyagi K, Kawakami K, Kinjo Y, Uezu K, Kinjo T, Nakamura K & Saito A (2005) CpG oligodeoxynucleotides promote the host protective response against infection with Cryptococcus neoformans through induction of interferon-gamma production by CD4 T cells. Clin Exp Immunol 140: 220-229.
27. Moayeri M, Haines D, Young HA & Leppla SH (2003) Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 112: 670-682.
28. Mock M & Fouet A (2001) Anthrax. Annu Rev Microbiol 55: 647-671.
29. Netea MG, Van der Meer JW & Kullberg BJ (2004) Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 12: 484-488.
30. Ojo-Amaize EA, Rubalcava B, Avery TL, Cottam HB, Matsumoto SS, Jolley WB & Robins RK (1990) Activation of the respiratory burst in murine phagocytes by certain guanine ribonucleosides modified at the 7 and 8 positions: possible involvement of a pertussis toxin-sensitive G-protein. Immunol Lett 23: 173-178.
31. Park JM, Greten FR, Li ZW & Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
32. Park JM, Ng VH, Maeda S, Rest RF & Karin M (2004) Anthrolysin O and other Gram-positive cytolysins are Toll-like receptor 4 agonists. J Exp Med 200: 1647-1655.
33. Pei J & Ficht TA (2004) Brucella abortus rough mutants are cytopathic for macrophages in culture. Infect Immun 72: 440-450.
34. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M & Montecucco C (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett 462: 199-204.
35. Pickering AK & Merkel TJ (2004) Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores. Infect Immun 72: 3069-3072.
36. Pickering AK, Osorio M, Lee GM, Grippe VK, Bray M & Merkel TJ (2004) Cytokine response to infection with Bacillus anthracis spores. Infect Immun 72: 6382-6389.
37. Popov SG, Popova TG, Grene E, et al. (2004) Systemic cytokine response in murine anthrax. Cell Microbiol 6: 225-233.
38. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K & Raz E (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
39. Ruthel G, Ribot WJ, Bavari S & Hoover TA (2004) Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis 189: 1313-1316.
40. Sato S, Takeuchi O, Fujita T, Tomizawa H, Takeda K & Akira S (2002) A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 14: 783-791.
41. Scheckelhoff M & Deepe GS Jr. (2005) A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun 73: 2129-2134.
42. Smee DF, Alaghamandan HA, Cottam HB, Jolley WB & Robins RK (1990) Antiviral activity of the novel immune modulator 7-thia-8-oxoguanosine. J Biol Response Mod 9: 24-32.
43. Smee DF, Alaghamandan HA, Gilbert J, et al. (1991) Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice. Antimicrob Agents Chemother 35: 152-157.
44. Steele AD, Warfel JM & D'Agnillo F (2005) Anthrax lethal toxin enhances cytokine-induced VCAM-1 expression on human endothelial cells. Biochem Biophys Res Commun 337: 1249-1256.
45. Takeda K, Kaisho T & Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
46. Tsan MF & Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukocyte Biol 76: 514-519.
47. Underhill DM & Ozinsky A (2002) Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 14: 103-110.
48. Warfel JM, Steele AD & D'Agnillo F (2005) Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 166: 1871-1881.
49. Welkos SL, Keener TJ & Gibbs PH (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51: 795-800.
50. Wongratanacheewin S, Kespichayawattana W, Intachote P, Pichyangkul S, Sermswan RW, Krieg AM & Sirisinha S (2004) Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Infect Immun 72: 4494-4502.
51. Yeo SJ, Yoon JG, Hong SC & Yi AK (2003) CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J Immunol 170: 1052-1061.